FDA Inspection 1053668 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1076406

The FDA completed an inspection of Octapharma Plasma, Inc. on May 3, 2018 in North Charleston, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 3, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
North Charleston, SC (United States)